GlobeNewswire Inc.··DelveinsightESR1-Mutated Breast Cancer Market Set to Surge at 9.6% CAGR as Novel Therapies Transform Treatment
ESR1-mutated breast cancer market projected to grow 9.6% through 2036, reaching USD 1.5B in 2025, driven by novel SERD therapies and VEPPANU's PROTAC approval.
PFELLYRHHBYAZNOLMA+2clinical trialsmarket forecast